Literature DB >> 30882193

Atrial flow regulator for severe drug resistant pulmonary arterial hypertension after congenital heart defect correction.

Alicja Dąbrowska-Kugacka1, Dariusz Ciećwierz2, Grzegorz Żuk2, Marcin Fijałkowski2, Antoni Ottowicz3, Joanna Kwiatkowska4, Ewa Lewicka5, Robert Sabiniewicz4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30882193      PMCID： PMC8086679          DOI： 10.5603/CJ.2019.0016

Source DB:  PubMed          Journal:  Cardiol J        ISSN： 1898-018X            Impact factor:   2.737


× No keyword cloud information.
  7 in total

1.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper
Journal:  Eur Respir J       Date:  2015-08-29       Impact factor: 16.671

2.  Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension.

Authors:  J Sandoval; J Gaspar; H Peña; L E Santos; J Córdova; K del Valle; A Rodríguez; T Pulido
Journal:  Eur Respir J       Date:  2011-02-24       Impact factor: 16.671

3.  Implantable atrial flow regulator for severe, irreversible pulmonary arterial hypertension.

Authors:  Mehul B Patel; Bennett P Samuel; Reda E Girgis; Matthew A Parlmer; Joseph J Vettukattil
Journal:  EuroIntervention       Date:  2015-10       Impact factor: 6.534

4.  Atrial septostomy with a predefined diameter using a novel occlutech atrial flow regulator improves symptoms and cardiac index in patients with severe pulmonary arterial hypertension.

Authors:  Ramasamy Rajeshkumar; Sreeja Pavithran; Kothandam Sivakumar; Joseph J Vettukattil
Journal:  Catheter Cardiovasc Interv       Date:  2017-09-01       Impact factor: 2.692

5.  Atrial septostomy in the treatment of severe pulmonary arterial hypertension.

Authors:  F Reichenberger; J Pepke-Zaba; K McNeil; J Parameshwar; L M Shapiro
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

6.  Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension.

Authors:  Marcin Kurzyna; Marek Dabrowski; Dariusz Bielecki; Anna Fijalkowska; Piotr Pruszczyk; Grzegorz Opolski; Janusz Burakowski; Michal Florczyk; Witold Z Tomkowski; Liliana Wawrzynska; Monika Szturmowicz; Adam Torbicki
Journal:  Chest       Date:  2007-04       Impact factor: 9.410

7.  Atrial septostomy in patients with end-stage pulmonary hypertension. No more needles but wires, energy and close anatomical definition.

Authors:  Roberto Baglini
Journal:  J Interv Cardiol       Date:  2012-09-10       Impact factor: 2.279
  7 in total
  2 in total

1.  Atrial flow regulator as a novel therapy for patients with chronic heart failure.

Authors:  Łukasz Lewicki; Robert Sabiniewicz; Janusz Siebert; Marek Szołkiewicz
Journal:  Cardiol J       Date:  2020-05-21       Impact factor: 2.737

2.  Decompression of the left heart chambers via atrial flow regulator: A new insight into heart failure treatment.

Authors:  Uğur Nadir Karakulak; Ergün Barış Kaya; Mehmet Levent Şahiner; Kudret Aytemir
Journal:  Anatol J Cardiol       Date:  2021-04       Impact factor: 1.596
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.